SRG Global (SRG) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
3 Jun, 2026Executive summary
Achieved record FY24 results with revenue of $1,069.3m (up 32%), EBITDA of $98.5m (up 23%), and EBIT(A) of $65.6m (up 31%) year-over-year.
EPS(A) increased 15% to 7.7cps and full-year dividend rose 13% to 4.5cps, fully franked, yielding over 6%.
Transitioned from net debt of $17.0m in FY23 to net cash of $17.8m in FY24, with 117% EBITDA to cash conversion.
Announced transformational acquisition of Diona for $111m, a market leader in water security and energy transition, expected to be 10% EPS accretive.
FY25 EBITDA guidance raised to $125m, including 10 months' contribution from Diona.
Financial highlights
Revenue grew 32% year-over-year to $1,069.3m, with EBITDA margin at 9.2% and EBIT(A) margin at 6.1%.
NPAT(A) increased 26% to $40.3m; EPS(A) up 15% to 7.7cps.
EBITDA to cash conversion at 117%, supporting strong liquidity.
Dividend per share increased to 4.5cps, up 13% year-over-year.
Robust balance sheet and liquidity, supporting growth and flexibility.
Outlook and guidance
FY25 EBITDA guidance increased to $125m, reflecting 27% growth and Diona integration.
Work in Hand at $3.0b, up 46% year-over-year, with 80% annuity/recurring earnings.
Opportunity pipeline of $8.5b supports long-term sustainable growth.
Positive exposure to growth sectors: water, defence, resources, transport, and energy transition.
High visibility for FY25 earnings, maintaining strong track record of guidance and delivery.
Latest events from SRG Global
- Record 1H FY26 results, upgraded guidance, and strong TAMS integration drive growth.SRG
H1 202628 May 2026 - Record FY25 growth, strong cash, and robust FY26 outlook with ~10% earnings growth guided.SRG
H2 202528 May 2026 - Record 1H FY25 results, profit guidance upgrade, and strong cash flow drive growth.SRG
H1 202528 May 2026 - $85m acquisition to drive 25% EPS growth, recurring revenue, and market leadership.SRG
M&A Announcement15 Dec 2025